Lacrinorm (Carbomer)

Carbomer is a high‑molecular‑weight polymer that swells when hydrated, creating a cross‑linked gel. This gel increases the thickness of the eye drop solution, slowing its clearance by tears and enhancing the contact time of the active ingredient with the eye, which can lead to better drug absorption and effect.

The dosage of Lacrinorm is determined by the prescribing ophthalmologist or pharmacist based on the specific eye drop formulation and the patient’s condition. The prescriber sets the appropriate volume and frequency of administration, and no standard dose can be provided without a professional recommendation.

Safety data for carbomer in pregnant or nursing individuals are limited. Lacrinorm should only be used if the potential benefit justifies any potential risk to the mother or infant. Healthcare providers should evaluate the risk‑benefit profile before prescribing it to pregnant or lactating patients.

To order Lacrinorm, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the enquiry, the sales team will request trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Lacrinorm uses carbomer, which is widely recognized for its high viscosity and gel‑forming properties. Compared with alternatives such as hyaluronic acid or cellulose derivatives, carbomer typically offers a more robust gel matrix and longer residence time, though the choice depends on formulation requirements, patient tolerance, and specific therapeutic goals.

Lacrinorm should be stored at room temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, direct sunlight, and extreme temperatures. Ensure the container is tightly closed to maintain the integrity of the gel matrix.

Lacrinorm is administered ocularly as part of an eye drop formulation. The prescribed number of drops is instilled onto the conjunctival sac of the eye, typically using a sterile dropper. Patients should follow the dosing instructions provided by their eye care professional.

The most serious risks involve hypersensitivity reactions, such as severe eye irritation, swelling, or allergic responses that may require discontinuation of the product. In rare cases, corneal edema or significant ocular inflammation can occur, necessitating immediate medical evaluation.

Individuals with a known allergy or hypersensitivity to carbomer or any component of the formulation should avoid using Lacrinorm. Patients with active severe ocular infections or uncontrolled inflammatory eye conditions should consult their ophthalmologist before use, as the gel may interfere with treatment.